Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Partial Seizures With or Without Secondary Generalization”

27 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 27 results

Not applicableStudy completedNCT01620840
What this trial is testing

Lacosamid-i.v.-Register

Who this might be right for
Epilepsy With Partial Onset Seizures With or Without Secondary Generalization
University Hospital Schleswig-Holstein 130
Large-scale testing (Phase 3)Study completedNCT01392768
What this trial is testing

Efficacy and Safety of Levetiracetam in Partial Seizures Control, With or Without Secondary Generalization

Who this might be right for
EpilepsyPartial Seizures
Ache Laboratorios Farmaceuticos S.A. 126
Large-scale testing (Phase 3)Study completedNCT03250377
What this trial is testing

Test the Safety/ Efficacy of Brivaracetam (BRV) Used as Adjunctive Treatment in Subjects >=16 Years of Age With Partial Seizures With or Without Secondary Generalization

Who this might be right for
Partial Seizures With or Without Secondary GeneralizationEpilepsy
UCB Biopharma SRL 207
Not applicableStudy completedNCT03082222
What this trial is testing

ZEDEBAC: Zebinix Effects in Dependency of Baseline Conditions

Who this might be right for
Focal Epilepsy
Eisai GmbH 246
Large-scale testing (Phase 3)Study completedNCT01710657
What this trial is testing

A Trial to Evaluate the Efficacy and Safety of Adjunctive Therapy With Lacosamide in Adults With Partial-Onset Seizures

Who this might be right for
EpilepsyPartial Onset Seizures
UCB Pharma SA 548
Not applicableStudy completedNCT01673282
What this trial is testing

Study Evaluating Changes in Total Drug Load and Seizure Frequency Using Vimpat® (Lacosamide) in Combination Therapy

Who this might be right for
Focal Epilepsy With and Without Secondary Generalization
UCB Pharma GmbH 315
Large-scale testing (Phase 3)Study completedNCT02124564
What this trial is testing

A Trial to Evaluate the Long Term Safety and Tolerability of Lacosamide Taken as Monotherapy in Adults With Partial-onset Seizures

Who this might be right for
EpilepsyPartial-onset Seizures
UCB Japan Co. Ltd. 19
Large-scale testing (Phase 3)Study completedNCT02192814
What this trial is testing

Open-label Study to Evaluate the Safety and Tolerability of iv Lacosamide in Japanese Adults With Partial-onset Seizures

Who this might be right for
EpilepsyPartial-onset Seizures
UCB Japan Co. Ltd. 9
Large-scale testing (Phase 3)Ended earlyNCT00698581
What this trial is testing

A Double-blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam in Subjects (≥ 16 to 75 Years Old) With Partial Onset Seizures

Who this might be right for
Epilepsy
UCB Pharma 88
Not applicableStudy completedNCT01098162
What this trial is testing

Vimpat® Added as Adjunctive Therapy to One Baseline Antiepileptic Drug

Who this might be right for
Epilepsies, Partial
UCB Pharma GmbH 576
Post-approval studies (Phase 4)Study completedNCT02726074
What this trial is testing

Trial Evaluating the Efficacy and Safety of Perampanel Added to Monotherapy in Participants With Partial Onset Seizures With or Without Secondary Generalization

Who this might be right for
Epilepsy
Eisai Korea Inc. 106
Large-scale testing (Phase 3)Study completedNCT00151879
What this trial is testing

Safety and Tolerability of Intravenous SPM 927 as Replacement for Oral SPM 927 in Subjects With Partial Seizures

Who this might be right for
Epilepsies, Partial
UCB Pharma 160
Not applicableStudy completedNCT04252846
What this trial is testing

Investigate Dosage, Effectiveness, and Safety of Perampanel When Used as First Add-on Therapy in Participants >=12 Years With Partial Onset Seizures With or Without Secondary Generalization or With Primary Generalized Tonic-Clonic Seizures Associated With Idiopathic Generalized Epilepsy

Who this might be right for
Idiopathic Generalized EpilepsyPartial Onset SeizuresGeneralised Tonic-Clonic Seizures
Eisai Limited 191
Large-scale testing (Phase 3)Study completedNCT03083665
What this trial is testing

Evaluate the Efficacy and Safety of Brivaracetam in Study Participants (>=16 to 80 Years of Age) With Epilepsy

Who this might be right for
Partial Seizures With or Without Secondary GeneralizationEpilepsy
UCB Biopharma SRL 449
Testing effectiveness (Phase 2)Study completedNCT00800215
What this trial is testing

A Trial to Investigate the Safety, Tolerability and Pharmacokinetics of Intravenous SPM 927

Who this might be right for
Epilepsy
UCB Pharma 60
Large-scale testing (Phase 3)Ended earlyNCT00699283
What this trial is testing

A Double-blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam in Subjects (≥ 16 to 75 Years Old) With Partial Onset Seizures

Who this might be right for
Epilepsy
UCB Pharma 62
Testing effectiveness (Phase 2)Study completedNCT00210652
What this trial is testing

An Open-Label Extension Study to Evaluate the Safety and Effectiveness of RWJ 333369 in Patients With Epilepsy

Who this might be right for
EpilepsyEpilepsies, Partial
SK Life Science, Inc. 47
Testing effectiveness (Phase 2)Ended earlyNCT04529954
What this trial is testing

Anti-Epilepsy Medication Valproate Administered Via ICV Route and Catheters and Pumps for CSF Infusion

Who this might be right for
Focal Epilepsy
Cerebral Therapeutics LLC 20
Large-scale testing (Phase 3)Study completedNCT00220415
What this trial is testing

A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Trial to Investigate the Efficacy and Safety of SPM 927 (200mg/Day and 400mg/Day) as Adjunctive Therapy in Subjects With Partial Seizures With or Without Secondary Generalization

Who this might be right for
Partial Seizures With or Without Secondary Generalization
UCB Pharma
Testing effectiveness (Phase 2)Study completedNCT02899611
What this trial is testing

A Dose Ranging Pilot Study for Intracerebroventricular (ICV) Delivery of Valproate in Subjects With Temporal Seizures

Who this might be right for
Epilepsy
Cerebral Therapeutics LLC 6
Load More Results